Herbal-based therapeutics for diabetic patients with SARS-Cov-2 infection

• Published in: Molecular biology reports Vol. 51; no. 1; p. 316
• Main Authors: Rasmi, Yousef, di Bari, Ighli, Faisal, Shah, Haque, Munima, Aramwit, Pornanong, da Silva, Aline, Roshani Asl, Elmira
• Format: Journal Article
• Language: English
• Published: Dordrecht Springer Netherlands 01.12.2024; Springer Nature B.V
• Subjects: ACE2; Angiotensin-converting enzyme 2; Animal Anatomy; Animal Biochemistry; Biomedical and Life Sciences; Comorbidity; Coronaviruses; COVID-19; Cytokine storm; Diabetes; Diabetes mellitus; Histology; Hyperglycemia; Infections; Life Sciences; Metabolic disorders; Molecular modelling; Morphology; Natural products; Review; Risk factors; Severe acute respiratory syndrome coronavirus 2; COVID-19; Inflammation; Diabetes; Respiratory tract infection; Herbal medication; Cytokine storm
• ISSN: 0301-4851; 1573-4978
• DOI: 10.1007/s11033-024-09291-1

Human SARS Coronavirus-2 (SARS-CoV-2) has infected more than 170 million people worldwide, being responsible for about 3.5 million deaths so far. Despite ongoing investigations, there is still more to understand the mechanism of COVID-19 infection completely. However, it has been evidenced that SARS-CoV-2 can cause Coronavirus disease (COVID-19) notably in diabetic people. Approximately 35% of the patients who died of this disease had diabetes. A growing number of studies have evidenced that hyperglycemia is a significant risk factor for severe SARS-CoV-2 infection and plays a key role in COVID-19 mortality and diabetes comorbidity. The uncontrolled hyperglycemia can produce low-grade inflammation and impaired immunity-mediated cytokine storm that fail multiple organs and sudden death in diabetic patients with SARS-CoV-2 infection. More importantly, SARS-CoV-2 infection and interaction with ACE2 receptors also contribute to pancreatic and metabolic impairment. Thus, using of diabetes medications has been suggested to be beneficial in the better management of diabetic COVID-19 patients. Herbal treatments, as safe and affordable therapeutic agents, have recently attracted a lot of attention in this field. Accordingly, in this review, we intend to have a deep look into the molecular mechanisms of diabetic complications in SARS-CoV-2 infection and explore the therapeutic potentials of herbal medications and natural products in the management of diabetic COVID-19 patients based on recent studies and the existing clinical evidence.